Details of the Drug

General Information of Drug (ID: DMKB8KF)

Drug Name
RG6421
Indication
Disease Entry ICD 11 Status REF
Cystic fibrosis CA25 Phase 1 [1]
Cross-matching ID
TTD ID
DU5W3E

References

1 Clinical pipeline report, company report or official report of Roche